InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,071.63
(
0.02%
)
US TECH 100
16,897.20
(
-0.96%
)
Dow Jones
38,460.92
(
-0.11%
)
Brent Oil
87.49
(
0.30%
)
Bitcoin
64,007.05
(
-0.43%
)
Post# of 1282
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

LasNubes

Send PM Follow Ignore
Followers 40
Posts 2492
Boards Moderated 0
Alias Born 04/07/2012

LasNubes

Re: None

Friday, 06/26/2015 11:19:47 AM

Friday, June 26, 2015 11:19:47 AM

Post# of 1282
LOS ANGELES, CA (June 24, 2015) – Lion Biotechnologies, Inc. (Nasdaq: LBIO), a biotechnology company that is developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TIL), today announced that it will join the Russell Global Index on June 26, according to a list of final additions posted June 19 on the FTSE Russell website.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up